NCT00575926 - Lingzhi for Cancer Children | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Study Completion Date

September 30, 2007

Conditions

Pediatric Cancers

Interventions

DRUG

LingZhi capsule

LingZhi or Placebo 300 mg x 4 or 300 mg x 6 capsules daily according to age group

Trial Locations (3)

Department of Pediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong

Department of Pediatrics, Queen Elizabeth Hospital, Hong Kong

Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors

collaborator

Prince of Wales Hospital, Shatin, Hong Kong

OTHER

collaborator

Queen Elizabeth Hospital, Hong Kong

OTHER

collaborator

Princess Margaret Hospital, Hong Kong

OTHER_GOV

lead

Chinese University of Hong Kong

OTHER